Journal of Medicinal Chemistry · 2004 · 51 citations · 37 references
Natural SciencesChemistryMedicinal ChemistryDrug DesignDrug DiscoveryOrganic ChemistryCoordination ChemistryDna ChemistryHeterocyclic ChemistryHeterocyclic CompoundsIntercalation CompoundsTopoisomerase InhibitorsAntiproliferative AgentsAntiproliferative Drug ActionCatalytic ActivityDna Topoisomerase I InhibitionFused Heterocyclic SystemsMolecular ChromophoresPreferred Orientation
New azaquinolizinium-type cations have been obtained from isochromane. The synthesis was completed over seven steps and included as the key feature an intramolecular Westphal condensation. This first example of the intramolecular process allowed the preparation of benzo[f]pyrido[2,1-a]phthalazinium and benzo[f]quino[2,1-a]phthalazinium salts, which were evaluated as DNA intercalators, DNA topoisomerase I inhibitors, and antiproliferative compounds. Both cationic systems behave as DNA intercalators and exhibit antiproliferative activity. The pentacyclic benzo[f]quino[2,1-a]phthalazinium cations also have an inhibitory effect on the catalytic activity of DNA topoisomerase I, without trapping of cleavage complexes. Structural characterization using density functional theory indicates that the fused ring systems are slightly nonplanar, and additional molecular modeling studies suggest a preferred orientation for the intercalating chromophores within a typical CpG or TpG intercalation site.
37
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Philip Skehan, Ritsa Storeng, Dominic A. Scudiero et al. · JNCI Journal of the National Cancer Institute · 1990 · 9.8K citations
Medicine, Oncology, Pharmacology +10